Published in Am J Gastroenterol on February 21, 2007
Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ (2012) 2.45
Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf (2009) 0.83
Current Diagnosis and Management of Suspected Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy. Gastroenterol Hepatol (N Y) (2014) 0.75
A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival. Curr Oncol (2016) 0.75
General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study. BMC Fam Pract (2016) 0.75
Clinical Characteristics of Patients with Untreated Achalasia. J Neurogastroenterol Motil (2017) 0.75
Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ (2008) 3.31
The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease. Am J Gastroenterol (2015) 2.51
Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol (2003) 2.39
Arthritis in Aboriginal Manitobans: evidence for a high burden of disease. J Rheumatol (2008) 2.31
Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. J Clin Epidemiol (2008) 2.19
Validity of a prescription claims database to estimate medication adherence in older persons. Med Care (2006) 2.06
Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol (2008) 2.04
The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology (2008) 1.79
Biphasic fracture risk in diabetes: a population-based study. Bone (2007) 1.68
Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology (2009) 1.59
Identifying priorities in methodological research using ICD-9-CM and ICD-10 administrative data: report from an international consortium. BMC Health Serv Res (2006) 1.45
Learning from the census: the Socio-economic Factor Index (SEFI) and health outcomes in Manitoba. Can J Public Health (2012) 1.22
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol (2013) 1.17
Osteoporosis-related fracture case definitions for population-based administrative data. BMC Public Health (2012) 1.11
Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol (2009) 1.09
Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Mult Scler (2012) 1.07
The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study. Neuroepidemiology (2012) 1.05
Establishing a regional bone density program: lessons from the Manitoba experience. J Clin Densitom (2003) 1.00
Fracture risk among First Nations people: a retrospective matched cohort study. CMAJ (2004) 0.96
Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. J Clin Psychopharmacol (2011) 0.96
Effectiveness of internet-based interventions for children, youth, and young adults with anxiety and/or depression: a systematic review and meta-analysis. BMC Health Serv Res (2014) 0.95
Bone mineral density and risk of postmenopausal breast cancer. Breast Cancer Res Treat (2010) 0.93
Tamoxifen use and osteoporotic fracture risk: a population-based analysis. J Clin Oncol (2008) 0.93
Comparison of anti-infective drug use in elderly persons in Manitoba, Nova Scotia, and Saskatchewan, Canada: relationship to drug insurance reimbursement policies. Am J Geriatr Pharmacother (2004) 0.92
What you see is what you get? Questioning the relationship between objective and subjective appraisals of neighbourhood resources in relation to health. Can J Public Health (2007) 0.88
Stereotyping as a barrier to collaboration: Does interprofessional education make a difference? Nurse Educ Today (2010) 0.87
Bone mineral density testing in healthy postmenopausal women. The role of clinical risk factor assessment in determining fracture risk. J Clin Densitom (2002) 0.86
Prescribing of psychotropic medications to the elderly population of a Canadian province: a retrospective study using administrative databases. PeerJ (2013) 0.85
The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data. Neuroepidemiology (2012) 0.82
The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol (2003) 0.81
Measurement equivalence of osteoporosis-specific and general quality-of-life instruments in Aboriginal and non-Aboriginal women. Qual Life Res (2009) 0.81
Demographic risk factors for fracture in First Nations people. Can J Public Health (2005) 0.80
The relationship between work hours and utilization of general practitioners in four Canadian provinces. Health Serv Res (2007) 0.80
Encouraging physician appropriate prescribing of non-steroidal anti-inflammatory therapies: protocol of a randomized controlled trial [ISRCTN43532635]. BMC Health Serv Res (2004) 0.78
Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis. J Fam Plann Reprod Health Care (2005) 0.75
Method of suicide attempt and reaction to survival as predictors of repeat suicide attempts: a longitudinal analysis. J Clin Psychiatry (2014) 0.75
Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis. Inflamm Bowel Dis (2017) 0.75
Quality and methodological challenges in Internet-based mental health trials. Telemed J E Health (2014) 0.75
Comparing resource utilization and gastrointestinal outcomes in patients treated with either standard-dose or high-dose proton pump inhibitors: a matched cohort study. Dig Dis Sci (2008) 0.75